First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 3.2 USD -2.14% Market Closed
Updated: May 15, 2024

Aquestive Therapeutics Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aquestive Therapeutics Inc
Selling, General & Administrative Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Selling, General & Administrative
-$35m
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Selling, General & Administrative
-$21.9B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
0%
Bristol-Myers Squibb Co
NYSE:BMY
Selling, General & Administrative
-$7.9B
CAGR 3-Years
-1%
CAGR 5-Years
-12%
CAGR 10-Years
-5%
Pfizer Inc
NYSE:PFE
Selling, General & Administrative
-$14.5B
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Selling, General & Administrative
-$10.4B
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Selling, General & Administrative
-$7.6B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-1%

See Also

What is Aquestive Therapeutics Inc's Selling, General & Administrative?
Selling, General & Administrative
-35m USD

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Selling, General & Administrative amounts to -35m USD.

What is Aquestive Therapeutics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
16%

Over the last year, the Selling, General & Administrative growth was 26%. The average annual Selling, General & Administrative growth rates for Aquestive Therapeutics Inc have been 14% over the past three years , 16% over the past five years .